Publications
Publications
December 2024
American Society of Hematology (ASH 2024)
We are excited as the PETAL team gets invited for oral and poster presentations at the 2024 American Society of Hematology (ASH) conference. We are thrilled to share our research and advance the conversation on T-cell lymphoma treatments.
Oral presentations
B. Poster presentations
October, 2024
July, 2024
Congratulations to Makoto Iwasaki, MD, PhD, on receiving the esteemed ASH Global Research Award from the American Society of Hematology (ASH) with the support of Caroline MacVicar! This award will support his research in developing machine learning models to predict T-cell lymphoma outcomes.
Makoto Iwasaki
Congratulations to Makoto Iwasaki, MD, PhD, on receiving the esteemed ASH Global Research Award from the American Society of Hematology (ASH) with the support of Caroline MacVicar! This award will support his research in developing machine learning models to predict T-cell lymphoma outcomes.
Makoto Iwasaki
Congratulations to Makoto Iwasaki, MD, PhD, on receiving the esteemed ASH Global Research Award from the American Society of Hematology (ASH) with the support of Caroline MacVicar! This award will support his research in developing machine learning models to predict T-cell lymphoma outcomes.
Makoto Iwasaki
Congratulations to Shambhavi Singh, MD, PhD, for being selected as a recipient of the 2024 ASH Hematology Opportunities for the Next-Generation of Research Scientists (HONORS) Award.
Shambhavi Singh
Congratulations to Shambhavi Singh, MD, PhD, for being selected as a recipient of the 2024 ASH Hematology Opportunities for the Next-Generation of Research Scientists (HONORS) Award.
Shambhavi Singh
Congratulations to Shambhavi Singh, MD, PhD, for being selected as a recipient of the 2024 ASH Hematology Opportunities for the Next-Generation of Research Scientists (HONORS) Award.
Shambhavi Singh
June 2024
T-cell Lymphoma Forum (TCLF) 2024
The Jain Lab T-cell lymphoma program was invited to give 2 oral presentations and 3 poster presentation on their global PETAL consortium - an incorporation of novel machine learning strategies to estimate patient outcomes for peripheral T-cell lymphoma.
Oral presentations
Incorporation of Novel Causal Inference Methods to Define Impact of Therapy Sequences in Relapsed and Refractory Mature T- and NK-Cell Neoplasms: A Global Study of the PETAL Consortium, Presented by: Mark N Sorial
Mark Sorial
Incorporation of Novel Causal Inference Methods to Define Impact of Therapy Sequences in Relapsed and Refractory Mature T- and NK-Cell Neoplasms: A Global Study of the PETAL Consortium, Presented by: Mark N Sorial
Mark Sorial
Incorporation of Novel Causal Inference Methods to Define Impact of Therapy Sequences in Relapsed and Refractory Mature T- and NK-Cell Neoplasms: A Global Study of the PETAL Consortium, Presented by: Mark N Sorial
Mark Sorial
B. Poster presentations
@2024 PETAL Consortium • All rights reserved
@2024 PETAL Consortium • All rights reserved
@2024 PETAL Consortium • All rights reserved